|
1
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
3
|
Rampone B, Schiavone B, Martino A, Viviano
C and Confuorto G: Current management strategy of hepatocellular
carcinoma. World J Gastroenterol. 15:3210–3216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Anthony PP: Hepatocellular carcinoma: An
overview. Histopathology. 39:109–118. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sandal T: Molecular aspects of the
mammalian cell cycle and cancer. Oncologist. 7:73–81. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kögel D, Fulda S and Mittelbronn M:
Therapeutic exploitation of apoptosis and autophagy for
glioblastoma. Anticancer Agents Med Chem. 10:438–449. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sofowora A, Ogunbodede E and Onayade A:
The role and place of medicinal plants in the strategies for
disease prevention. Afr J Tradit Complement Altern Med. 10:210–229.
2013.PubMed/NCBI
|
|
8
|
Maximowicz and Mém: Acad. Imp. Sci.
St.-Pétersbourg Divers Savans 9. Prim Fl Amur. 296:1859.
|
|
9
|
Kakarla L, Allu PR, Rama C and Botlagunta
M: A review on biological and chemical properties of Cyperus
species. Res J Pharm Biol Chem Sci. 5:1142–1155. 2014.
|
|
10
|
Rahmatullah M, Ferdausi D, Mollik AH,
Jahan R, Chowdhury MH and Haque WM: A survey of medicinal plants
used by Kavirajes of Chalna area, Khulna district, Bangladesh. Afr
J Tradit Complement Altern Med. 7:91–97. 2009.PubMed/NCBI
|
|
11
|
Lee SI, Choi H, Jeon H, Baek NI, Kim SH,
Kim HJ, Cho CH, Ahn HC, Yang JH, Chae BS, et al: Antioxidant
phenolic components from the whole plant extract of Cyperus
amuricus Max. Korean J Pharmacogn. 39:233–236. 2008.
|
|
12
|
Sharma N, Sharma VK and Seo SY: Screening
of some medicinal plants for anti-lipase activity. J
Ethnopharmacol. 97:453–456. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nicholson DW and Thornberry NA: Caspases:
Killer proteases. Trends Biochem Sci. 22:299–306. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ayed-Boussema I, Bouaziz C, Rjiba K,
Valenti K, Laporte F, Bacha H and Hassen W: The mycotoxin
Zearalenone induces apoptosis in human hepatocytes (HepG2) via
p53-dependent mitochondrial signaling pathway. Toxicol In Vitro.
22:1671–1680. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hartwell LH and Kastan MB: Cell cycle
control and cancer. Science. 266:1821–1828. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Morgan DO: Cyclin-dependent kinases:
Engines, clocks, and microprocessors. Annu Rev Cell Dev Biol.
13:261–291. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Knudsen ES and Knudsen KE: Tailoring to
RB: Tumour suppressor status and therapeutic response. Nat Rev
Cancer. 8:714–724. 2008. View Article : Google Scholar
|
|
18
|
Li W, Sanki A, Karim RZ, Thompson JF, Soon
Lee C, Zhuang L, McCarthy SW and Scolyer RA: The role of cell cycle
regulatory proteins in the pathogenesis of melanoma. Pathology.
38:287–301. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jin Z and El-Deiry WS: Overview of cell
death signaling pathways. Cancer Biol Ther. 4:139–163. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang H, Ao M, Wu J and Yu L: TNFα and
Fas/FasL pathways are involved in 9-Methoxycamptothecin-induced
apoptosis in cancer cells with oxidative stress and G2/M cell cycle
arrest. Food Chem Toxicol. 55:396–410. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Breckenridge DG and Xue D: Regulation of
mitochondrial membrane permeabilization by BCL-2 family proteins
and caspases. Curr Opin Cell Biol. 16:647–652. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Portt L, Norman G, Clapp C, Greenwood M
and Greenwood MT: Anti-apoptosis and cell survival: A review.
Biochim Biophys Acta. 1813:238–259. 2011. View Article : Google Scholar
|
|
23
|
Leibowitz B and Yu J: Mitochondrial
signaling in cell death via the Bcl-2 family. Cancer Biol Ther.
9:417–422. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Abu-Qare AW and Abou-Donia MB: Biomarkers
of apoptosis: Release of cytochrome c, activation of caspase-3,
induction of 8-hydroxy-2′-deoxyguanosine, increased
3-nitrotyrosine, and alteration of p53 gene. J Toxicol Environ
Health B Crit Rev. 4:313–332. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Green DR: Apoptotic pathways: Ten minutes
to dead. Cell. 121:671–674. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Boulares AH, Yakovlev AG, Ivanova V,
Stoica BA, Wang G, Iyer S and Smulson M: Role of poly(ADP-ribose)
polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP
mutant increases rates of apoptosis in transfected cells. J Biol
Chem. 274:22932–22940. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ozören N and El-Deiry WS: Cell surface
death receptor signaling in normal and cancer cells. Semin Cancer
Biol. 13:135–147. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lazebnik YA, Takahashi A, Moir RD, Goldman
RD, Poirier GG, Kaufmann SH and Earnshaw WC: Studies of the lamin
proteinase reveal multiple parallel biochemical pathways during
apoptotic execution. Proc Natl Acad Sci USA. 92:9042–9046. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Twist EM, Clark HF, Aden DP, Knowles BB
and Plotkin SA: Integration pattern of hepatitis B virus DNA
sequences in human hepatoma cell lines. J Virol. 37:239–243.
1981.PubMed/NCBI
|
